IRCT20240604062002N1招募中2 期
systemic administration and intralesional injection of rituximab in patients with pemphigus vulgaris with oral lesions
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •People over 18 years old with pemphigus vulgaris with oral lesions
- •Patients who have not had a therapeutic response to corticosteroid administration
- •Patients for whom rituximab has been started
排除标准
- •Pregnancy and breastfeeding
- •People who have coagulation problems
- •Patients with infection at the site of the lesion
- •Rituximab contraindications include hypersensitivity to it or its components
- •Having hepatitis B
- •Having cardiovascular diseases
- •Having malignant diseases
研究者
相似试验
招募中
不适用
Role of tranexamic acid in reducing blood loss in hip fracture surgeriesCTRI/2019/10/021667Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram
进行中（未招募）
1 期
Comparison of PV-10 to Chemotherapy or Oncolytic Viral Therapy for Treatment of Malignant Melanoma of the Skiocally Advanced Cutaneous MelanomaMedDRA version: 21.1Level: PTClassification code 10025650Term: Malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-000317-78-ITPROVECTUS BIOPHARMACEUTICALS, INC.225
已完成
不适用
Comparison of local versus systemic tranexamic acid in total knee replacementCTRI/2017/04/008401Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram138
已完成
不适用
Comparison of combined intralesional injection of glucantime and interferon gamma with intralesional glucantime alone in the treatment of cutaneous leishmaniasisCutaneous Leishmaniasis.Protozoal diseasesB50,B51,B5IRCT2015012420740N2Mashhad University of Medical Sciences, Vice Chancellor for Research90
已完成
3 期
The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathyChemotherapy induced neuropathy.IRCT20200425047202N1Shahid Beheshti University of Medical Sciences40